Revised Interpretation of the Hain Lifescience GenoType MTBC To Differentiate Mycobacterium canettii and Members of the Mycobacterium tuberculosis Complex.
Chloé Loiseau;
Daniela Brites;
Irmgard Moser;
Francesc Coll
;
Christine Pourcel;
Suelee Robbe-Austerman;
Vincent Escuyer;
Kimberlee A Musser;
Sharon J Peacock;
Silke Feuerriegel;
+4 more...
Thomas A Kohl;
Stefan Niemann;
Sebastien Gagneux;
Claudio U Köser
;
(2019)
Revised Interpretation of the Hain Lifescience GenoType MTBC To Differentiate Mycobacterium canettii and Members of the Mycobacterium tuberculosis Complex.
Antimicrobial Agents and Chemotherapy, 63 (6).
ISSN 0066-4804
DOI: 10.1128/AAC.00159-19
Using 894 phylogenetically diverse genomes of the Mycobacterium tuberculosis complex (MTBC), we simulated in silico the ability of the Hain Lifescience GenoType MTBC assay to differentiate the causative agents of tuberculosis. Here, we propose a revised interpretation of this assay to reflect its strengths (e.g., it can distinguish some strains of Mycobacterium canettii and variants of Mycobacterium bovis that are not intrinsically resistant to pyrazinamide) and limitations (e.g., Mycobacterium orygis cannot be differentiated from Mycobacterium africanum).
Item Type | Article |
---|---|
Elements ID | 131393 |
ORCID: https://orcid.org/0000-0002-7882-2325
ORCID: https://orcid.org/0000-0002-0232-846X